1300022I university of maryland, baltimore; to 18-0010.B1C1.0120--22 base task order funding; biod can 8470038 $59,220

Ended Awarded Last action

Contract number
75N93019F00131
Awardee
Awarding agency
Obligated
$1,617,485

Award facts

Opportunity
Contract value 100% obligated
$1,617,485.35 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 6 offers Multiple Award, Fair Opportunity
Pricing
Cost No Fee
Place of performance
Baltimore, MD 21201, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00008 $16,021
Supplemental Agreement for work within scope P00007 $0
Supplemental Agreement for work within scope P00006 $0
Supplemental Agreement for work within scope P00005 $0
Other Administrative Action P00004 · UMB vteu HHSN272201300022I to HHSN27200001-18-0010.B1C1.0120. $0
Other Administrative Action P00003 · UMB vteu to HHSN27200001-18-0010.B1C1.0120. The purpose of this modification is to extend the period of performance of task area c option 1. $0
Other Administrative Action P00002 · The purpose of this modification is to extend the period of performance of task area c option 1. $0
Exercise an Option P00001 $1,542,244
Original award $59,220

About this award

This is a delivery order issued under the Vaccine and Treatment Evaluation Units (VTEU) contract, which is a multiple award indefinite delivery/indefinite quantity (IDIQ) contract managed by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH) under the Department of Health and Human Services (HHS). The $59,220 award was made to the University of Maryland, Baltimore (UMB) to provide vaccine treatment evaluation services as part of the VACCINE TREATMENT EVALUATION UNITS (VTEUS) major program. This order does not utilize any set-aside designations. UMB, as the prime contractor, will leverage its expertise and facilities to deliver these services, with support from its parent organization, the University System of Maryland (USM). The potential value of the overall contract is $1,617,485.35, with a completion date of November 30, 2024.

Quick answers

Who was awarded contract 75N93019F00131?

75N93019F00131 was awarded to University Of Maryland, Baltimore by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on April 15, 2019.

How much is contract 75N93019F00131 worth?

The government has obligated $1,617,485 on 75N93019F00131.

Is contract 75N93019F00131 an order under another contract?

Yes. 75N93019F00131 is a delivery order under HHSN272201300022I, an indefinite delivery contract, on Vaccine and Treatment Evaluation Units (VTEU).

Was contract 75N93019F00131 competed?

The extent of competition for 75N93019F00131 was full and open competition. The government received 6 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award